Saudo Arabija - anglų - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ms pharma saudi (msps), saudi arabia - memantine hydrochloride - film-coated tablet - 20 mg

Saudo Arabija - anglų - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

deef pharmaceutical industries, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg

Australija - anglų - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride -

Europos Sąjunga - anglų - EMA (European Medicines Agency)

merz pharmaceuticals gmbh   - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer’s disease.

Europos Sąjunga - anglų - EMA (European Medicines Agency)

mylan pharmaceuticals limited - memantine hydrochloride - alzheimer disease - other anti-dementia drugs, psychoanaleptics, - treatment of patients with moderate to severe alzheimer’s disease.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated populat

Malta - anglų - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - galantamine - film-coated tablet - galantamine - psychoanaleptics